Title:
GALACTOSIDE INHIBITOR OF GALECTIN-3 AND ITS USE FOR TREATING PULMONARY FIBROSIS
Document Type and Number:
WIPO Patent Application WO/2014/067986
Kind Code:
A8
Abstract:
The present invention relates to a compound of the general formula (I) for pulmonary administration. The compound of formula (I) is suitable for treating pulmonary fibrosis, such as Idiopathic pulmonary fibrosis in a mammal. Furthermore the present invention concerns a method for treatment of pulmonary fibrosis, such as Idiopathic pulmonary fibrosis in a human subject.
Inventors:
NILSSON ULF (SE)
LEFFLER HAKON (SE)
HENDERSON NEIL (GB)
SETHI TARIQ (GB)
MACKINNON ALISON (GB)
LEFFLER HAKON (SE)
HENDERSON NEIL (GB)
SETHI TARIQ (GB)
MACKINNON ALISON (GB)
Application Number:
PCT/EP2013/072691
Publication Date:
April 14, 2016
Filing Date:
October 30, 2013
Export Citation:
Assignee:
GALECTO BIOTECH AB (DK)
International Classes:
A61K31/70; A61K9/00; A61K31/7056; A61M11/00; A61M15/00; A61P11/00
Attorney, Agent or Firm:
KJERRUMGAARD, Lars (Ole Maaløes Vej 3, 2200 Copenhagen N, DK)
Download PDF: